In the latest in an ongoing series of quarterly briefings looking at major (and some minor) developments in the world of tobacco, we assess the latest performance of the major multinationals, important cannabis and NPD/NGP updates, the reviewed economic growth projections for the world’s key markets and what to look for in the next quarter.
In June, the FDA finalised its guidance for submitting PMTAs for ENDS and e-liquids. Among other things, manufacturers and importers have to demonstrate that marketing of novel products would be appropriate for the protection of public health. It also includes recommendations for constituent or chemical testing and provides additional resources to aid application submissions. Notably, the FDA has also proposed to shorten the deadline for PMTAs. This was triggered by a Maryland court decision which found that the agency exceeded its authority when it pushed back the due date to 2022. In its filling, the FDA proposed to set a deadline for PMTA submissions “no sooner” than 10 months after the court’s final decision. Consequentially, the deadline could potentially be brought forward, ie to sometime in 2020.
San Francisco is set to become the first US city to ban sales of e-cigarettes. It is expected that the measure will be enforced at the beginning of 2020, however, it is likely that legal challenges will be mounted. San Francisco is the home of Juul Labs, the company that dominates the US vapour market with over 70% value market share.
The City Council of Beverly Hills in the US has voted to prohibit sales of all tobacco products, including e-cigarettes. The measure, which is first of its kind in the country, will enter into effect in 2021. The ruling extends to channels such as petrol/gas stations, convenience stores and pharmacies. Cigar lounges and hotels are exempt from the law.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE! Home Page